Background Evidence indicates that genetic variations in the GYP(B-A-B) hybrid genes are associated with protection against malaria. Therefore, this study aims to characterize the GYP(B-A-B) hybrid alleles among northern Thais, Burmese, and Karen with and without a previous history of malaria infection. Methods A total of 709 DNA samples were genotyped to identify GYP(B-A-B) hybrids using PCR-sequence specific primers (PCR-SSP) combined with Sanger sequencing. Additionally, some DNA samples (n = 243) were also tested with high-resolution melting (HRM) analysis. Results In our sampled populations, 14/87 (16.0%), 3/34 (8.8%), 0/16 (0%), and 1/18 (5.6%) of northern Thais, Burmese, Karen, and other minorities in Myanmar with a previous history of malaria infection, respectively, were identified with GYP(B-A-B) hybrid genes, whereas individuals without a history of malaria infection were 24/155 (15.5%), 5/183 (2.6%), and 4/216 (1.9%) in northern Thais, Burmese, and Karen, respectively. In the latter groups, DNA sequences showed that 17/155 (11.0%) northern Thais were GYP*Mur/GYPB heterozygotes and the other 6/155 (3.9%) were GYP*Thai/GYPB heterozygotes. The remaining one (0.6%) sample was a GYP*Mur/GYP*Mur homozygote. Among Burmese, 3/183 (1.6%) were GYP*Mur/GYPB heterozygotes and 1/183 (0.5%) was GYP*Thai/GYPB heterozygote. The remaining one (0.5%) sample being a GYP*Mur/GYP*Mur homozygote. Among Karen samples, all four were GYP*Mur/GYPB heterozygotes. Conclusion Across all studied populations, GYP*Mur was the predominant allele, followed by GYP*Thai. In addition, genotyping results obtained by HRM were consistent with PCR-SSP combined with Sanger sequencing. A statistically non-significant association was noted for the glycophorin GYP(B-A-B) hybrids and malaria infection. Our findings provide insight into genetic variations of GYP(B-A-B) hybrid alleles among populations in the Thailand-Myanmar border area. This information could be used as a guideline to identify compatible blood products for transfusion and to prevent alloimmunization.
No takes yet. Share an insight, caveat, or question.
Srichankhot et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: